If given by the intra-arterial route, the immediate effect of the hydrogenated alkaloids of ergot is unpredictable. Vasodilation is obtained in some patients only. However, it was found that in those cases who do not react, the vessels respond more easily to the release of sympathetic tone, proving that, nevertheless, the drug has had an (potential) effect, probably on the neurovascular apparatus. This effect could be demonstrated for many hours and is, therefore, of considerable therapeutic interest. Even with the higher local concentrations possible by the intra-arterial route, the hydrogenated alkaloids of ergot still did not exhibit any adrenolytic action on the peripheral blood vessels in man. showed that dihydroergocornine may suppress or reverse the blood pressor response to adrenalin, although it was unable to do the same to the vasoconstrictor action of adrenalin on the digital vessels, at least in doses which were sufficient to produce a reversal on the blood pressure.
Besides these effects, Goetz and Katz14
showed that dihydroergocornine may suppress or reverse the blood pressor response to adrenalin, although it was unable to do the same to the vasoconstrictor action of adrenalin on the digital vessels, at least in doses which were sufficient to produce a reversal on the blood pressure.
Whereas hypotension and bradyeardia are very constant and can be obtained with the greatest regularity, the vasodilator effect on the peripheral vessels is a capricious effect not invariably produced by intravenous Hydergine. As the blood vessels of the human extremity do not contain vasodilator fibers, ablation of the vasomotor tone alone does not always seem sufficient to produce vasodilatation. As a matter of fact, the failure of sympathicolytic drugs to produce vasodilatation has been quoted in support of the assumption that the blood vessels of the human skin are not supplied by active vasodilators.23 FIG. 1. The optical principle underlying the plethysmographic method employed for recording cutaneous blood flow. That part of the pipette which is filled with alcohol (A.C.) acts like a biconvex lens and intensifies the light, giving the appearance of a dark grey or black band on the tracing. The pipette containing air behaves like two plain parallel plates to the light. The light therefore just passes through it giving the grey shade on the film. The meniscus (M) reflects the light and casts a shadow on the filmhence the white line between the dark and light shades of grey. The etch marks of the calibration on the pipette absorbs the light and appears as white lines on the film. The system is therefore always calibrated whatever the enlargement. The tap (C) and the rubber tubing (T) permit adjustment of the meniscus. Two pipettes of equal diameter are mounted next to each other in the same optical system. Thus the blood flow in two limbs can be simultaneously recorded.
Contrary to our experience with intravenous injections of the hydrogenated alkaloids of ergot, Bircher and Cerlettil6 have reported that the intra-arterial injection of Hydergine invariably produced peripheral dilatation in the anesthetized cat. As the validity of experimental data obtained in animals cannot be assumed to pertain to man, particularly with reference to the sympathetic nervous system,23 the question arose as to whether in man, too, a more constant and reliable peripheral dilator action could be obtained by the intra-arterial route of administration. This question has become of particular interest since, within recent years, intra-arterial (as opposed to intravenous) therapy in cases of peripheral vascular diseases has found many protagonists.'7-'9 25 Bircher and Cerletti16 were able to demonstrate that in the anesthetized cat dihydroergocornine readily produced reversal of the adrenalin effect on the peripheral blood vessels, whereas, as already mentioned, our own investigations'4 failed to elicit this effect in man.
Our failure, which referred to intravenous injections, challenged an inquiry into the possibility of producing adrenalin reversal by administering the ergot alkaloids by the intraarterial route, when the drug could reach the peripheral neurovascular apparatus in higher concentrations. METHOD For the present investigations 19 patients were subjected to the following procedures:
(1) Intravenous injection of dihydroergocornine or Hydergine.
(2) Intra-arterial injection of dihydroergocornine or Hydergine.
(3) Intra-arterial injection of dihydroergocornine or Hydergine, followed by intra-arterial injection of adrenalin.
(4) Intravenous injection of dihydroergocornine or Hydergine, followed by adrenalin.
(5) Intra-arterial injection of a mixture containing dihydroergocornine and adrenalin.
It will be readily appreciated that by simultaneous recording of the vascular reactions in both limbs, following the intra-arterial injection into one, the effect of the drug on the other limb may be similar to that of an intravenous injection, provided the drug is not destroyed or escapes from the vascular tree during its course through the capillary network.
Ten of the patients were normal from the cardiovascular aspect, varying between the ages of 18 and 49. Two patients suffered from essential hypertension, being 55 and 64 years of age, respectively. One patient, aged 42, had had a stellatectomy. Four patients suffered from acrocyanosis and two from Raynaud's phenomenon. They were selected for these investigations because they regularly exhibited a high vasomotor tone.
In the beginning, 0.3 mg. dihydroergocornine was given, usually into the right femoral artery. Later we used Hydergine, 0.5 to 1.5 cc., throughout.
RESULTS
( arterial blood flow of the limb was only seen twice.
Two extreme reactions are shown in figure  2A and B. Figure 2A was obtained in a young female patient suffering from typical acrocyanosis. As can be seen at a glance, the intraarterial injection of 0.5 mg. Hydergine into the right femoral artery did not induce any response in the arterial tree of the limb whatsoever. The vessels, being under a high vasomotor tone at the time of the injection, remained constricted, and within 20 minutes there was no change in the height of the pulse volume, digital volume or the rate of arterial inflow. The lack of response is well appreciated from the cuttings of the plethysmogram (fig. 3A-A'). Figure 2B was obtained from a patient, 55 years of age, who had suffered from essential hypertension for many years. In his case the intra-arterial injection of 0.5 mg. Hydergine into the right femoral artery produced an immediate increase in the arterial circulation, as judged by the rise in pulse volume, digital volume and, particularly, the rate of arterial inflow. The pulse volume, which recorded 0.008 cc. in both toes before the injection, increased in the right within a few seconds and became 3B-B' ). The rate of arterial inflow increased from 12 to 42 cc. per miniute for 100 cc. of tissue during the same period. The blood flow through the left leg, which was simultaneously recorded, showed no change in this case, although in some patients a temporary decrease could be registered, as judged by the height of the pulse volume and the rate of arterial inflowx, provided the intraarterial injectioni produced dilatation of the injected limb.
As already indicated above, the intra-arterial ilje tion of llydergille, although it may not produce any direct peripheral response, eventually brings about the same systemic effect on the circulation as an intravenous injection of the same magnitude. Therefore, provided it is large enough, it will produce a fall in the systemic blood pressure and bradyeardia.
Although the intra-arterial injection of Hydergine may produce a powerful vasodilator reaction in the injected limb, it is only occasionally that this is followed by a similar reaction in the remaining limbs.
Similarly, such side-effects as may occur with intravenous injections may also be noted after the same amount given by the arterial route.
( is produced by the increase in the blood temperature resulting from the return of heated blood from the immersed extremity.22 This causes ablation of the central sympathetic tone in the hypothalamus. In cases exhibiting a high vasomotor tone, and therefore having an initially diminished blood flow through the limb, such as cases of acrocyanosis and Raynaud's phenomenon, it regularly takes considerably longer to initiate dilatation.
As vasodilatation induced by body heating is produced by central ablation of vasoconstrictor tone, it occurs simultaneously in either both lower or both upper extremities, although it does not necessarily occur simultaneously in both the upper and the lower extremities, as the vasomotor tone is generally known to be higher in the latter.28 Figure 4 demonstrates the response to reflex body heating following an intra-arterial injection of Hydergine in a patient in whom it did not produce any immediate visible peripheral hemodynamic effect. It refers to a young woman suffering from acrocyanosis, in whom the vessels are normally under a high vasomotor tone and peripheral blood flow is diminished. The injection of 0.5 mg. Hydergine into the right femoral artery did not have any effect whatsoever on the peripheral blood flow in that leg. Twenty minutes after the intraarterial injection, the digital blood flow was still negligible in both limbs. It can be seen in figure 4 that the response of the blood flow in the right leg differs greatly from that in the normal left leg, both in regard to onset and to extent. Within five minutes, the vasomotor tone begins to relax and, after 10 minutes, dilatation is well on its way. Within 15 minutes, the pulse volume has risen to 0.020 cc. and after 20 (fig. 6 ).
How long following the injection can this difference in the response to reflex body heating following an intra-arterial injection of Hydergine be demonstrated? To answer this question, four patients were subjected to reflex body heating at various time intervals following the injection of Hydergine. In every one, the effect was still demonstrable after eight hours and in one fully 48 hours after the intraarterial injection ( fig. 7) .
(3) The Effect of an Intra-arterial Injection of Adrenalin following the Intra-arterial Injection of Hydergine: As Goetz and Katz14 demonstrated, the vasoconstrictor effect on the digital circulation of an intravenous or subcutaneous injection of adrenalin is not affected by a preceding intravenous injection of dihydroergocornine in man, whereas it is so in the cat.'6 It might be argued that the discrepancy between our results in man and those obtained in the animal were due to the higher concentration possible in the latter. Obviously, if such an effect could be demonstrated in man, it would be of some practical importance.
The question was, therefore, reinvestigated following intra-arterial injection of Hydergine, when higher concentrations reach the peripheral vessels.
Five subjects were chosen iii whom the intra- arterial injection of Hydergine produced an immediate peripheral vasodilatation. When this had reached its maximum and was well established, adrenalin was injected intra-H7YDERGINE AND DLYlD)RO)ElRGOCOItNINE ANI) CI1t(tTLATIO)N arterially. A typical response is illustrated in figure 8 , which was obtained inl a patient showing no signs of any cardiovascular disease or disorder. As can be seen, the injection of 0.5 mg. Hydergine into the right femoral artery produced an immediate increase in pulse volume, digital volume and the rate of arterial blood flow. Seventeen minutes after the intraarterial injection, 0.10 mg. of adrenalin was injected intra-arterially into the same limb, which resulted ill an abrupt antid powerful constriction of the arterial tree. The pulse volume, which before varied around 0.01 cc., disappeared completely, the digital volume fell to well below the level recorded before the injection of dihydroergocornine and the arterial inflow on venous congestion could not be recorded. This constriction of the arterial tree was sustained for more than five minutes. W\hen the blood vessels relaxed, the blood flo\ returned to the highest value recorded after the injection of Hydergine, and the degree of reactive hyperemia was far in excess of that normally seen. In the opposite limb, the effect of the intraarterial adrenalin was only slight and less than it would have been, had the injection been by the intravenous route.
Both the degree of vasodilatation, obtained from the intra-arterial injection of Hydergine, and the degree of vasoconstriction, recorded during the subsequent injection of adrenalin, are very well appreciated by consulting the cuttings from the plethysmogram (fig. 9) .
Similarly, vasoconstriction produced by subcutaneous or intravenous injection of adrenalin is not affected by preceding intra-arterial injection of Hydergine.
(4) The Effect of an Intra-arterial Injection of a Mixture of Hydergine and Adrenalin: We know from previous investigations'4 that dihydroergocornine does not affect the potency of adrenalin when mixed in vitro and given intravenously. This holds good for the intraarterial route as well. In figure 10 , 0.5 mg. dihydroergocornine plus 0.1 mg. of adrenalin were injected into the right femoral artery and the effect compared with an intra-arterial injection of 0.1 mg. of adrenalin, simultaneously administered in the left limb. Although the immediate reaction is the same in both limbs, that is, a complete arrest of the peripheral circulation for about five minutes, there is a difference when the circulation resumes. In the "normal" left leg, a moderate degree of reactive hyperemia is observed, the pulse volume and the rate of arterial inflow only temporarily assume a higher level and return to the original values within 30 minutes. In the right leg, however, in which Hydergine had been added, recovery is not only more rapid but the reactive hyperemia reaches a much higher level and the vessels go on to full dilatation and stay at that level, while under observation for the next 60 minutes. At the end of that time, the pulse volume in the right leg recorded 0.020 cc. as against 0.006 cc. in the left leg.
DISCUSSION
The results of the treatment of peripheral vascular diseases by the hydrogenated alkaloids of ergot have not been entirely satisfactory. Although these drugs are sympathicolytic in action, their effect on the peripheral vessels, when administered by the intravenous route, is unpredictable. In contrast, Bircher and Cerletti reported that, when given arterially, these drugs invariably produced peripheral vasodilatation in the cat, which seemed to fit in with the observations of Edwards and associates.25 They state that the results from intraarterial therapy are better than with any other type of treatment-excluding sympathectomy.
In our experience, the effect of the hydrogenated alkaloids of ergot is the same whether given by the arterial or by the venous route. Only in about half the patients did we record any peripheral vasodilatation following intraarterial injection of Hydergine or dihydroergocornine, as judged by a rise in skin temperature, pulse volume and rate of arterial inflow, but failed in the remaining limbs to produce any visible effects. This failure was particularly striking when it occurred in patients with a high vasomotor tone, who, theoretically, ezz "-L u.W should be most responsive to the administration of sympathicolytic drugs. In this, our observations did not agree with the results of Bircher and Cerletti,16 obtained in the anesthetized cat. However, this is not very surprising as it is well known that the results obtained in the animal cannot necessarily be transferred to man, particularly, when the sympathetic nervous system is involved.
Although it may be concluded that Hydergine had no effect in those cases where it failed to produce vasodilatation, this would be misleading. The intra-arterial injection of Hydergine did produce changes, most likely on the neurovascular apparatus, which are only revealed when we start dilating the vessels, either by body heating or by producing reactive hyperemia. We then discover that the vessels of the injected extremity respond sooner and to a greater degree to these procedures.
Rothlin4 has already drawn attention to the fact that the various effects of the ergot alkaloids can be divided into two groups; those which are immediately visible and those which are latent and will only be apparent when the respective organ is stimulated. No doubt we are dealing here with the same type of reaction; the intra-arterial injection of Hydergine produces both, the immediately visible and latent or potential effects. Although in the past only the former effects have been considered, the latter are no less important on account of their therapeutic potentialities. It would appear that therapy with the hydrogenated alkaloids of ergot could be made more effective by combining the intra-arterial injection with other vasodilator procedures, notably body heating, but not necessarily applied to such a degree as to produce general vasodilatation throughout the body.
Vasodilator therapy suffers from one major disadvantage. If given by the oral, subcutaneous or intravenous route, dilatation, if effective, affects all vessels throughout the body. If all vessels are normal, as in many vascular "disorders," there is no harm in this. But if the resistance in one area, due to arterial "disease" or other reasons, should differ from the remainder, vasodilatation may affect the delicately balanced distribution of the blood considerably and may lead to a marked movement of blood from the area with the higher into that with the lower resistance. Consequently, vasodilator therapy in cases of arterial disease may achieve the exact contrary to what it sets out to do.
Intra-arterial instead of intravenous therapy obviously offers a way out of this dilemma. It is able to overcome some of the difficulties inherent in intravenous therapy with vasodilator and sympathicolytic drugs. Its advantages are the possibility of producing more powerful dilatation by virtue of the selective effect and the higher local concentration, achieved from smaller doses than are necessary with intravenous therapy. Thus, the effect of intra-arterial therapy is purely local, without dilatation in the rest of the body with its accompanying side-effects. In this, intra-arterial therapy can be compared with treatment by paravertebral block. However, it is obvious that unless such drugs which are to be given intraarterially produce vasodilatation constantly, repeated arterial puncture will not be justified, and intra-arterial therapy has come in for some criticism in this respect. 26 In a previous communication,14 we reported that dihydroergocornine suppressed or reversed the rise in blood pressure, following the injection of adrenalin. Although we could not demonstrate a similar effect with respect to the effect of adrenalin on the peripheral vessels, Bircher and Cerletti16 subsequently found that in the cat, Hydergine, when given intraarterially, abolishes and reverses peripheral vasoconstriction normally produced by adrenalin. We have now confirmed our previous results and can state that Hydergine, when given intravenously or by the intra-arterial route, exhibits no adrenolytic action on the peripheral vessels in man.
SUMMARY
The effect of intra-arterial Hydergine or dihydroergocornine on the peripheral blood vessels has been recorded and compared with the blood flow in the contralateral limb.
The immediate result is unpredictable, vasodilatation occurring in about half of the cases. In none of our cases was there ever any direct GOETZ vasoconstrictor action recorded. In principle, the effect was, therefore, the same as after an intravenous injection.
Although the intra-arterial injection of the hydrogenated alkaloids of ergot may not produce any visible effects on the peripheral blood vessels, the injection has not been without effect, as it does change their responsiveness to the release of the central vasoconstrictor tone. It was found that after an intra-arterial injection of Hydergine, reflex vasodilatation, as produced by body heating, occurs considerably earlier and proceeds to higher levels than in the contralateral normal limb.
The intra-arterial injection of the hydrogenated alkaloids of ergot produces, therefore, both visible and potential changes in the peripheral blood vessels. The potential changes can be demonstrated for many hours following the original injection and are of considerable therapeutic interest.
The vasoconstrictor effect of adrenalin on the peripheral blood vessels is not affected by preceding intra-arterial injections of Hydergine or dihydroergocornine. It is, therefore, confirmed that in man the hydrogenated alkaloids of ergot have no adrenergic properties in respect to the peripheral circulation.
The reactive hyperemia, observed following the temporary arrest of the peripheral circulation as produced by adrenalin, is greater and more lasting if this was preceded by an intraarterial injection of Hydergine or dihydroergocornine.
In some respects, the results are contrary to observations made in the animal. This stresses the caution which has to be exercised, in trying to apply to man results obtained in animal experiments.
The special merits of intra-arterial, as opposed to intravenous therapy, are discussed with special reference to the treatment of cases of peripheral vascular diseases. Mesmo in le plus alte concentrationes local que es possibile per le administration intraarterial, le hydrogenate alkaloides de ergota non exhibiva ulle action adrenolytic super le peripheric vasos sanguinee de humanos.
